Injection/Infusion
AJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225MG/1.5ML
Summary
AJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225MG/1.5ML — Injection/Infusion containing Fremanezumab. Hong Kong Registration No. HK-67139. Certificate Holder: TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED. Date of Registration: 12 Jul, 2021.
Product NameAJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225MG/1.5ML
Registration No.HK-67139
Certificate HolderTEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Holder AddressFLAT/RM 2303, 23/F, MIRA PLACE TOWER A, 132 NATHAN ROAD, TSIM SHA TSUI, KOWLOON
IngredientsFremanezumab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration12 Jul, 2021
ATC codesN02CD03
ATC Classification
ATC level 1
N Nervous System
All ATC groupsN02
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。